Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

• Status: Completed
• Trial end date: 2020-12-14
• Target enrollment: 0
• Participant gender: Female

Summary

multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Insulin, Long-Acting

Criteria

Inclusion Criteria:

• pregnant women with gestational diabetes mellitus

• between 24-28 weeks gestation

Exclusion Criteria:

• other endocrinological abnormalities